Literature DB >> 7561760

Site-specific alteration of transmissible gastroenteritis virus spike protein results in markedly reduced pathogenicity.

S Bernard1, H Laude.   

Abstract

The pathogenicity of neutralization-resistant mutants of the enteric coronavirus transmissible gastroenteritis virus (TGEV) was examined in the newborn piglet. The parental virus (Purdue-115 strain), as well as several mutants selected using monoclonal antibodies (MAbs) directed to antigenic sites A and B, caused an acute enteritis with 100% mortality. By contrast, most of the site D (MAb 40.1) mutants exhibited a strongly reduced enteropathogenicity, leading to the survival of animals inoculated with up to 1000-fold the 100% lethal dose of parental virus. Such a phenotypical change was correlated with point mutations or a small deletion, all located within the S gene sequence coding for the Pro-145 to Cys-155 segment of the mature polypeptide. These observations suggest that an N-terminal subregion of the S molecule is an essential determinant for pathogenesis in TGEV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561760     DOI: 10.1099/0022-1317-76-9-2235

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity.

Authors:  B Schultze; C Krempl; M L Ballesteros; L Shaw; R Schauer; L Enjuanes; G Herrler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 2.  Sialic acids as receptor determinants for coronaviruses.

Authors:  Christel Schwegmann-Wessels; Georg Herrler
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

3.  Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence.

Authors:  C M Sánchez; A Izeta; J M Sánchez-Morgado; S Alonso; I Sola; M Balasch; J Plana-Durán; L Enjuanes
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  Sialic acid binding activity of transmissible gastroenteritis coronavirus affects sedimentation behavior of virions and solubilized glycoproteins.

Authors:  C Krempl; G Herrler
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus.

Authors:  C Krempl; B Schultze; H Laude; G Herrler
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Binding of transmissible gastroenteritis coronavirus to cell surface sialoglycoproteins.

Authors:  Christel Schwegmann-Wessels; Gert Zimmer; Hubert Laude; Luis Enjuanes; Georg Herrler
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus.

Authors:  Christel Schwegmann-Wessels; Sandra Bauer; Christine Winter; Luis Enjuanes; Hubert Laude; Georg Herrler
Journal:  Virol J       Date:  2011-09-12       Impact factor: 4.099

8.  Novel porcine epidemic diarrhea virus variant with large genomic deletion, South Korea.

Authors:  Seongjun Park; Sanghyun Kim; Daesub Song; Bongkyun Park
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

9.  In vitro inhibition of transmissible gastroenteritis coronavirus replication in swine testicular cells by short hairpin RNAs targeting the ORF 7 gene.

Authors:  Lei He; Yan-ming Zhang; Ling-juan Dong; Min Cheng; Jing Wang; Qing-hai Tang; Gang Wang
Journal:  Virol J       Date:  2012-08-28       Impact factor: 4.099

10.  Experimental feline enteric coronavirus infection reveals an aberrant infection pattern and shedding of mutants with impaired infectivity in enterocyte cultures.

Authors:  Lowiese M B Desmarets; Ben L Vermeulen; Sebastiaan Theuns; Nádia Conceição-Neto; Mark Zeller; Inge D M Roukaerts; Delphine D Acar; Dominique A J Olyslaegers; Marc Van Ranst; Jelle Matthijnssens; Hans J Nauwynck
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.